BPG is committed to discovery and dissemination of knowledge
Observational Study
Copyright: ©Author(s) 2026.
World J Hepatol. Mar 27, 2026; 18(3): 114768
Published online Mar 27, 2026. doi: 10.4254/wjh.v18.i3.114768
Table 1 Demography of the participants, n (%)
Variable(s)
Liver disease category
Total
χ2
P value
Control
Cases (cirrhosis)
Age of participants (in years)
≤ 309 (15.0)9 (15.0)18 (15.0)0.0001.000
31-4010 (16.7)10 (16.7)20 (16.7)
41-5019 (31.7)19 (31.7)38 (31.7)
51-6014 (23.3)14 (23.3)28 (23.3)
≥ 618 (13.3)8 (13.3)16 (13.3)
Range19-7119-7119-71
mean ± SD44.32 ± 11.9644.57 ± 12.1144.44 ± 11.99
Gender of participants
Female21 (35.0)21 (35.0)42 (35.0)0.0001.000
Male39 (65.0)39 (65.0)78 (65.0)
Table 2 Comparison of splenic stiffness measurement and key laboratory parameters between cirrhotic patients and controls, median (interquartile range)/mean ± SD
Parameter
Cirrhotics (n = 60)
Controls (n = 60)
1P value
Splenic stiffness (kPa)56.8 (36.4-88.9)17.9 (14.2-20.6)< 0.001
Platelet count (× 109/L)85 (65-110)220 (190-250)< 0.001
Serum albumin (g/L)30.2 ± 5.142.8 ± 3.6< 0.001
Total bilirubin (μmol/L)40.5 (22.3-78.6)12.6 (9.8-15.4)< 0.001
INR1.6 ± 0.31.1 ± 0.1< 0.001